Evaluation of Fever Occurring in Labor in Patients Receiving Epidural Anesthesia



Status:Completed
Conditions:Infectious Disease
Therapuetic Areas:Immunology / Infectious Diseases
Healthy:No
Age Range:18 - Any
Updated:4/2/2016
Start Date:October 2006
End Date:May 2009
Contact:Christine Preslicka, Rn
Email:Cpreslicka@memorialcare.org
Phone:562-933-2755

Use our guide to learn which trials are right for you!

Evaluation of Intrapartum Fever in Patients Receiving Epidural Anesthesia

Briefly, the investigators propose to evaluate nulliparous (first time mothers) patients
beyond 36 0/7 weeks' gestation in active labor who already have received epidural anesthesia
and have an intrauterine pressure catheter (IUPC) in place. Any patient who then develops a
single temperature elevation of > 38 degrees will be eligible for inclusion and consented
for the study. Maternal blood will be drawn immediately, one hour later and at delivery.
Amniotic fluid will be aspirated from the pressure catheter; the first 1-2 cc will be
discarded and the remainder will be evaluated for gram stain, culture, glucose level,
interleukin-6 (IL-6), and proteomics. All placentas will be sent for routine pathologic
examination. Cord blood will be obtained at birth for routine studies. Both maternal and
cord blood will be sent for proteomic evaluation (defined). The patients with amniotic fluid
that has a positive gram stain and culture will be defined as the infected group, and the
patients with amniotic fluid that has a negative gram stain and culture will be defined as
the uninfected group. Differences in clinical presentation and laboratory assessments,
including proteomics, will be compared between the two groups to determine if there are any
markers that might prove to be useful in distinguishing between these two entities (epidural
fever with and without actual infection).

Historically the diagnosis of chorioamnionitis (an infection of the membranes surrounding
the fetus) for patients in labor has been made on the basis of multiple clinical variables
such as maternal fever, fetal tachycardia, uterine tenderness, or foul smelling vaginal
discharge. The diagnosis also takes into account a clinical picture consistent with risk
factors such as prolonged labor and prolonged rupture of membranes. Since most of these
findings are not specific, chorioamnionitis becomes the diagnosis of exclusion unless there
is another explanation for the fever. Randomized studies have clearly shown that maternal
antibiotics and neonatal septic work-ups are indicated once the diagnosis of
chorioamnionitis has been made. Neonatal sepsis is a severe infection of the blood stream.
Such policies have important implications for health care providers, on the impact of
medical costs, and on the duration of hospital stay. This becomes especially true for the
newborn that is transferred to the neonatal intensive care unit (NICU) for sepsis
evaluation. Often times, these newborns are prophylactically treated with antibiotics based
on the suspicion of an infection, while waiting for finalized blood culture results. Since
newborn sepsis is such a difficult diagnosis to make, many more newborns are treated than
actually have the disease and the length of their hospital stay may be significantly
increased.

Over the past 15 years, both observational and randomized trials have observed an increase
in maternal fever associated with epidural anesthesia in labor. These trials have shown
increased ranges from 10 - 15% over baseline rates and an increased relative risk of 1.5 to
15 fold, and even up to 70 fold in one study, over the rates seen in women not receiving
epidural anesthesia. After correcting for duration of labor and other confounding variables,
these increases remained present. Since epidural fever is virtually impossible to
distinguish from chorioamnionitis-related fever, these women are almost all treated with
antibiotics and given the diagnosis of infection. This approach also has tremendous impact
on the evaluation and care of the newborn. Two specific studies evaluated this impact on the
neonate. Lieberman found that babies of mothers given epidural anesthesia were more likely
to be evaluated for sepsis (34 vs. 9%) and treated with antibiotics (15 vs. 4%). Similarly,
Philips found the same increase (25 vs. 16% and 19 vs. 11%). Both studies had very low rates
of confirmed neonatal sepsis. On a national basis, the cost of this confusion nationally is
tremendous.

There is one known way to distinguish between true chorioamnionitis in labor and
non-infectious fever due to the epidural anesthesia. Gibbs and colleagues found that
amniotic fluid aspirated from an intrauterine pressure catheter, a device commonly utilized
for monitoring contractions in labor, could be used to accurately make the diagnosis of
infection using gram stain and culture. More recently, many papers have shown that low
glucose levels and elevated IL-6 in amniotic fluid were also accurate tests for infection.
While these markers could in theory be used for distinguishing between epidural fever and
true chorioamnionitis, most patients do not require such a device and this approach would
not likely gain widespread favor. Alternatively, however, this approach could be used as a
research tool in women who already have such a catheter in place to determine if there are
additional non-invasive clinical or laboratory markers to distinguish one from the other.

Recently proteomic assessment has become an extremely effective tool in determining if there
are certain markers for various diseases. Proteomics is the determination of the structure,
function, and expression of all of the corresponding proteins that are encoded within the
genome structure. It can also be defined as the "fingerprint" of a disease process. It
involves running tandem mass spectometry on the fluid of interest. Such an approach could be
extremely valuable both in determining whether the mother actually has chorioamnionitis and,
if so, whether there are better markers for neonatal sepsis.

Inclusion Criteria:

- Nulliparous

- Maternal age > 18 years of age

- Estimated gestational age (EGA) > 36 0/7 weeks

- Active labor (> 4 cm dilated)

- Epidural anesthesia

- IUPC in place prior to development of fever

- Temperature of > 38 degrees

- Consents to study

Exclusion Criteria:

- Multiparous

- Maternal age < 18 years of age

- External tocometer
We found this trial at
2
sites
Long Beach, California 90801
?
mi
from
Long Beach, CA
Click here to add this to my saved trials
Orange, California 92686
?
mi
from
Orange, CA
Click here to add this to my saved trials